Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19

[1]  Qianchuan Zhao,et al.  Contribution of CD4+ T cell-mediated inflammation to diarrhea in patients with COVID-19 , 2022, International Journal of Infectious Diseases.

[2]  Thomas P. Fabrizio,et al.  SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells , 2022, Nature Immunology.

[3]  C. Locht,et al.  Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination , 2022, NPJ vaccines.

[4]  D. Generali,et al.  Patients’ Engagement in Early Detection of COVID-19 Symptoms: An Observational Study in the Very Early Peak of the Pandemic in Italy in 2020 , 2022, International journal of environmental research and public health.

[5]  R. Xu,et al.  Mesenchymal stem cell treatment for COVID-19 , 2022, eBioMedicine.

[6]  Gaurav D. Gaiha,et al.  Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19 , 2022, Clinical Immunology.

[7]  A. Schulz,et al.  Protein Expression of AEBP1, MCM4, and FABP4 Differentiate Osteogenic, Adipogenic, and Mesenchymal Stromal Stem Cells , 2022, International journal of molecular sciences.

[8]  Waleed Aljabr,et al.  Evaluation of the Levels of Peripheral CD3+, CD4+, and CD8+ T Cells and IgG and IgM Antibodies in COVID-19 Patients at Different Stages of Infection , 2022, Microbiology spectrum.

[9]  D. Annane,et al.  Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial , 2022, Critical Care.

[10]  Qi Yuan,et al.  Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19 , 2022, Stem Cell Research & Therapy.

[11]  N. Garg,et al.  A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis , 2022, Diagnostics.

[12]  L. Daines,et al.  Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms , 2022, Pathogens.

[13]  Jan Rožanc,et al.  Mesenchymal Stem Cells Isolated from Paediatric Paravertebral Adipose Tissue Show Strong Osteogenic Potential , 2022, Biomedicines.

[14]  M. Kim,et al.  State of the Art: The Immunomodulatory Role of MSCs for Osteoarthritis , 2022, International journal of molecular sciences.

[15]  A. Sedaghat,et al.  Mesenchymal Stem Cell therapy for COVID-19-induced ARDS patients. A successful phase1, randomized, control-placebo group, clinical trial , 2022 .

[16]  A. Zamani,et al.  The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review , 2022, Stem cell research & therapy.

[17]  E. Opara,et al.  Effect of Alginate Microbead Encapsulation of Placental Mesenchymal Stem Cells on Their Immunomodulatory Function , 2022, Annals of Biomedical Engineering.

[18]  Yuqiang Zheng,et al.  Study of the biological characteristics of human umbilical cord mesenchymal stem cells after long-time cryopreservation , 2022, Cell and Tissue Banking.

[19]  J. Blankson,et al.  CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses , 2022, The Journal of clinical investigation.

[20]  D. Jin,et al.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies treatment for COVID-19 patients: a meta-analysis , 2022, medRxiv.

[21]  Hui Liu,et al.  When stem cells meet COVID-19: recent advances, challenges and future perspectives , 2022, Stem cell research & therapy.

[22]  J. Tu,et al.  Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases , 2022, Stem Cell Research & Therapy.

[23]  M. Yousefi,et al.  Serum levels of vitamin D and immune system function in patients with COVID-19 admitted to intensive care unit , 2022, Gene Reports.

[24]  Suliman Khan,et al.  The COVID-19 infection in children and its association with the immune system, prenatal stress, and neurological complications , 2022, International journal of biological sciences.

[25]  M. Pepper,et al.  Mesenchymal Stromal Cells: a Possible Reservoir for HIV-1? , 2022, Stem Cell Reviews and Reports.

[26]  Luis Pinzon-Herrera,et al.  Immunomodulatory functions of human mesenchymal stromal cells are enhanced when cultured on HEP/COL multilayers supplemented with interferon-gamma , 2021, Materials today. Bio.

[27]  J. V. van Dongen,et al.  Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19 , 2021, Nature immunology.

[28]  Simona Baghai Sain,et al.  Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection , 2021, Nature.

[29]  R. Sheervalilou,et al.  Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients , 2021, Journal of Drug Delivery Science and Technology.

[30]  J. Kwagyan,et al.  Diagnostic accuracy of a rapid diagnostic test for the early detection of COVID-19 , 2021, Journal of Clinical Virology.

[31]  Svenia P. Jose,et al.  Anti-inflammatory effect of Kaba Sura Kudineer (AYUSH approved COVID-19 drug)-A Siddha poly-herbal formulation against lipopolysaccharide induced inflammatory response in RAW-264.7 macrophages cells , 2021, Journal of Ethnopharmacology.

[32]  Xiaomin Yan,et al.  Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine , 2021, Clinical Microbiology and Infection.

[33]  Bo Zhang,et al.  Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial , 2021, eBioMedicine.

[34]  Sathish Kumar Karuppannan,et al.  The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection , 2021, Archives of Virology.

[35]  M. Ionescu.  COVID‐19 skin lesions are rarely positive at RT‐PCR test: the macrophage activation with vascular impact and SARS‐CoV‐2‐induced cytokine storm , 2021, International journal of dermatology.

[36]  L. Rochette,et al.  Exosomes contribution in COVID-19 patients’ treatment , 2021, Journal of Translational Medicine.

[37]  A. Faried,et al.  Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19 , 2021, Regenerative Engineering and Translational Medicine.

[38]  R. Handgretinger,et al.  Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS , 2021, Journal of intensive care medicine.

[39]  Z. A. Khan,et al.  Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients , 2021, Cells.

[40]  F. Inchingolo,et al.  Mesenchymal Stem Cells: The Secret Children’s Weapons against the SARS-CoV-2 Lethal Infection , 2021, Applied Sciences.

[41]  R. Xu,et al.  Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial , 2020, Signal Transduction and Targeted Therapy.

[42]  M. Soleimani,et al.  Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series , 2021, Stem cell research & therapy.

[43]  A. Bertoni,et al.  Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis , 2021, Stem Cell Reviews and Reports.

[44]  Arefeh Basiri,et al.  Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment , 2021, Stem cell reviews and reports.

[45]  H. Niknejad,et al.  Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs , 2021, Stem cell reviews and reports.

[46]  A. Bayés‐Genís,et al.  Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives , 2020, Thorax.

[47]  V. Volarevic,et al.  Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome , 2020, Analytical cellular pathology.

[48]  A. Gorji,et al.  Potential roles of micronutrient deficiency and immune system dysfunction in the coronavirus disease 2019 (COVID-19) pandemic , 2020, Nutrition.

[49]  Min Zheng,et al.  A systematic review of SARS-CoV-2 vaccine candidates , 2020, Signal Transduction and Targeted Therapy.

[50]  Abdulrahim A. Sajini,et al.  The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients , 2020, Stem cells international.

[51]  F. Krammer.  SARS-CoV-2 vaccines in development , 2020, Nature.

[52]  S. Ciesek,et al.  Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells , 2020, Stem Cell Reports.

[53]  D. Covas,et al.  Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19 , 2020, Stem Cell Reviews and Reports.

[54]  A. Gylfason,et al.  Humoral Immune Response to SARS-CoV-2 in Iceland , 2020, The New England journal of medicine.

[55]  E. Michalopoulos,et al.  Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection , 2020, World journal of stem cells.

[56]  A. Akbari,et al.  Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia , 2020, Stem Cell Research & Therapy.

[57]  Lanjuan Li,et al.  Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 , 2020, Frontiers of Medicine.

[58]  Haiying Wu,et al.  Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells , 2020, Medicine.

[59]  Ssang-Goo Cho,et al.  Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatmen , 2020, BMB reports.

[60]  Hua-Hsuan Mei,et al.  A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report , 2020, Stem Cell Research & Therapy.

[61]  U. Das.  Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19 , 2020, Aging and disease.

[62]  I. Gürsel,et al.  Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection , 2020, Turkish journal of biology = Turk biyoloji dergisi.

[63]  Hua Qin,et al.  Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics , 2020, Protein & Cell.

[64]  F. Yu,et al.  SARS-CoV-2 infection and stem cells: Interaction and intervention , 2020, Stem Cell Research.

[65]  H. Qi,et al.  Mesenchymal Stem Cell-based Therapy for COVID-19: Possibility and Potential. , 2020, Current Stem Cell Research & Therapy.

[66]  Madhan Jeyaraman,et al.  Cellular Therapy: Shafts of Light Emerging for COVID-19. , 2020, Stem cell investigation.

[67]  Shaoda Ren,et al.  Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia , 2020, Stem Cell Research & Therapy.

[68]  Juntang Lin,et al.  Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury , 2020, Stem Cell Research & Therapy.

[69]  M. Mahmoudi,et al.  Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes , 2020, Medical Hypotheses.

[70]  David A. Drew,et al.  Real-time tracking of self-reported symptoms to predict potential COVID-19 , 2020, Nature Medicine.

[71]  V. Sengupta,et al.  Exosomes Derived From Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. , 2020, Stem cells and development.

[72]  L. O’Driscoll,et al.  Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment , 2020, Drug Discovery Today.

[73]  X. Tang,et al.  Antibody responses to SARS-CoV-2 in patients with COVID-19 , 2020, Nature Medicine.

[74]  E. Deffune,et al.  Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients , 2020, Medical Hypotheses.

[75]  Yan Jin,et al.  Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019 , 2020, Stem cells translational medicine.

[76]  M. Khanna,et al.  Mesenchymal Stem Cells (MSCs) as a Novel Therapeutic Option for nCOVID-19—A Review , 2020, Open Journal of Regenerative Medicine.

[77]  M. Matucci-Cerinic,et al.  COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs , 2020, Turkish journal of medical sciences.

[78]  Rozhgar A. Khailany,et al.  Genomic characterization of a novel SARS-CoV-2 , 2020, Gene Reports.

[79]  A. Ardeshirylajimi,et al.  Mesenchymal Stem Cell Therapy for COVID-19: Present or Future , 2020, Stem Cell Reviews and Reports.

[80]  Dong Yang,et al.  Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  X. Wang.  MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment. , 2020, European review for medical and pharmacological sciences.

[82]  A. Corsico,et al.  Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use , 2020, Cells.

[83]  Yan Liu,et al.  Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.

[84]  K. Shi,et al.  Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.

[85]  E. Holmes,et al.  The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.

[86]  Gianpaolo Ronconi,et al.  Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. , 2020 .

[87]  Fabian J Theis,et al.  SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways , 2020, Nature Medicine.

[88]  A. Shetty.  Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia , 2020, Aging and disease.

[89]  Arthur S Slutsky,et al.  Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target , 2020, Intensive Care Medicine.

[90]  T. Palaga,et al.  Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. , 2020, Asian Pacific journal of allergy and immunology.

[91]  Matthew R. McKay,et al.  Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies , 2020, bioRxiv.

[92]  Min Wu,et al.  Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects , 2020, Signal Transduction and Targeted Therapy.

[93]  J. O. Lee,et al.  Alteration of fatty acid oxidation by increased CPT1A on replicative senescence of placenta-derived mesenchymal stem cells , 2020, Stem Cell Research & Therapy.

[94]  M. Uhrberg,et al.  HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3 , 2019, Journal of clinical medicine.

[95]  T. Severson,et al.  CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities , 2019, Nature Communications.

[96]  R. Sheervalilou,et al.  Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection. , 2019, Materials science & engineering. C, Materials for biological applications.

[97]  A. Abraham,et al.  Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome , 2019, Stem cells translational medicine.

[98]  G. Dreyfuss,et al.  U1 snRNP regulates cancer cell migration and invasion , 2019, bioRxiv.

[99]  Yanbo Zhang,et al.  Mesenchymal Stem Cells for Regenerative Medicine , 2019, Cells.

[100]  Yongmin Yan,et al.  MSC: immunoregulatory effects, roles on neutrophils and evolving clinical potentials. , 2019, American journal of translational research.

[101]  A. Atashi,et al.  Parvovirus B19 Infection in Human Bone Marrow Mesenchymal Stem Cells Affects Gene Expression of IL-6 and TNF-α and also Affects Hematopoietic Stem Cells Differentiation , 2019, Indian Journal of Hematology and Blood Transfusion.

[102]  Jian-guo Li,et al.  Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Clinical Trial in China , 2019, Stem cells international.

[103]  Takeshi Ichinohe,et al.  Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome , 2019, Front. Microbiol..

[104]  S. Braun,et al.  Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway , 2018, Scientific Reports.

[105]  Yuri Pritykin,et al.  Epigenetic control of innate and adaptive immune memory , 2018, Nature Immunology.

[106]  R. Harman,et al.  Equine mesenchymal stromal cells from different tissue sources display comparable immune-related gene expression profiles in response to interferon gamma (IFN)-γ. , 2018, Veterinary immunology and immunopathology.

[107]  Lei Li,et al.  HIV glycoprotein gp120 enhances mesenchymal stem cell migration by upregulating CXCR4 expression. , 2018, Biochimica et biophysica acta. General subjects.

[108]  A. Arsenijević,et al.  Modulation of autophagy as new approach in mesenchymal stem cell-based therapy. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[109]  Liang Xie,et al.  Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application , 2018, Stem cells international.

[110]  E. Alizadeh,et al.  Watercress-based electrospun nanofibrous scaffolds enhance proliferation and stemness preservation of human adipose-derived stem cells , 2018, Artificial cells, nanomedicine, and biotechnology.

[111]  M. Rahmati-Yamchi,et al.  An in vitro examination of the antioxidant, cytoprotective and anti-inflammatory properties of chrysin-loaded nanofibrous mats for potential wound healing applications , 2018, Artificial cells, nanomedicine, and biotechnology.

[112]  Yaoyao Chen,et al.  Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord , 2018, Scientific Reports.

[113]  S. Ghaderian,et al.  Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review , 2018, Stem Cell Reviews and Reports.

[114]  T. Meulia,et al.  Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model , 2018, Stem Cell Research & Therapy.

[115]  N. Zarghami,et al.  Antioxidant effects of chrysin-loaded electrospun nanofibrous mats on proliferation and stemness preservation of human adipose-derived stem cells , 2017, Cell and Tissue Banking.

[116]  D. Falzarano,et al.  SARS and MERS: recent insights into emerging coronaviruses , 2016, Nature Reviews Microbiology.

[117]  Ivan Martin,et al.  International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. , 2016, Cytotherapy.

[118]  C. Xiang,et al.  Comparative analysis of biological characteristics of adult mesenchymal stem cells with different tissue origins. , 2015, Asian Pacific journal of tropical medicine.

[119]  Jaume Torres,et al.  Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome , 2015, Virology.

[120]  K. Whartenby,et al.  Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. , 2014, World journal of stem cells.

[121]  W. Fibbe,et al.  Adipose Tissue‐Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow‐Derived Counterparts , 2013, Stem cells translational medicine.

[122]  Jiyuan Zhang,et al.  Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients , 2013, AIDS.

[123]  Jung Min Lee,et al.  Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. , 2012, International immunopharmacology.

[124]  T. Ritter,et al.  Mesenchymal stem cell effects on T-cell effector pathways , 2011, Stem Cell Research & Therapy.

[125]  I. Rasooli,et al.  Lipid Peroxidation Inhibition, Superoxide Anion and Nitric Oxide Radical Scavenging Properties of Thymus daenensis and Anethum graveolens Essential Oils , 2011 .

[126]  I. Martin,et al.  In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications. , 2009, Tissue engineering. Part A.

[127]  K. Atkinson,et al.  Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. , 2008, Stem cells and development.

[128]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[129]  P. Veys,et al.  Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. , 2008, Blood.

[130]  E. Wherry,et al.  Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. , 2007, Immunity.

[131]  Franca Fagioli,et al.  Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow , 2006, Journal of cellular biochemistry.

[132]  G. Sukhikh,et al.  Comparison of Mesenchymal Stem Cells Obtained from Different Human Tissues , 2005, Bulletin of Experimental Biology and Medicine.

[133]  OUP accepted manuscript , 2022, Stem Cells Translational Medicine.

[134]  M. Sitkovsky,et al.  T Cell Subsets and T Cell-Mediated Immunity , 2019, Nijkamp and Parnham's Principles of Immunopharmacology.

[135]  M. Parnham,et al.  Nijkamp and Parnham's Principles of Immunopharmacology , 2019 .

[136]  H. Han,et al.  Aging of bone marrow mesenchymal stromal/stem cells: Implications on autologous regenerative medicine. , 2017, Bio-medical materials and engineering.

[137]  V. Starostin,et al.  Mesenchymal stem cells: Sources, phenotype, and differentiation potential , 2006, Biology Bulletin.

[138]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..